 | • レポートコード：QYR9ST07256 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：機械・装置 |
| Single User | ￥828,800 (USD5,600) | ▷ お問い合わせ |
| Enterprise License | ￥1,657,600 (USD11,200) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の二重特異性抗体治療法市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。二重特異性抗体治療法の種類別には、Fcリージョンベアリング、Fc領域欠如に、用途別には、骨科学、肺、呼吸器疾患、腫瘍学、遺伝子治療に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・二重特異性抗体治療法の種類別市場規模：Fcリージョンベアリング、Fc領域欠如 ・二重特異性抗体治療法の用途別市場規模：骨科学、肺、呼吸器疾患、腫瘍学、遺伝子治療 ・二重特異性抗体治療法の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Creative-biolabs、PharmAbcine、Sorrento Therapeutics、Patheon ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.The Bispecific Antibody Therapeutic market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bispecific Antibody Therapeutic.
This study focuses on the production side and consumption side of Bispecific Antibody Therapeutic, presents the global Bispecific Antibody Therapeutic market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Bispecific Antibody Therapeutic capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Bispecific Antibody Therapeutic by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.
This report includes the following manufacturers; we can also add the other companies as you want.
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
…
Market Segment by Product Type
Bearing An Fc Region
Lacking An Fc Region
Market Segment by Application
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Bispecific Antibody Therapeutic status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Bispecific Antibody Therapeutic manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Bispecific Antibody Therapeutic are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Bispecific Antibody Therapeutic Market Size Growth Rate by Type
1.3.2 Bearing An Fc Region
1.3.3 Lacking An Fc Region
1.4 Market Segment by Application
1.4.1 Global Bispecific Antibody Therapeutic Market Share by Application (2019-2025)
1.4.2 Osteology
1.4.3 Pulmonary
1.4.4 Respiratory Diseases
1.4.5 Oncology
1.4.6 Gene Therapy
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Bispecific Antibody Therapeutic Production Value 2014-2025
2.1.2 Global Bispecific Antibody Therapeutic Production 2014-2025
2.1.3 Global Bispecific Antibody Therapeutic Capacity 2014-2025
2.1.4 Global Bispecific Antibody Therapeutic Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Bispecific Antibody Therapeutic Market Size CAGR of Key Regions
2.2.2 Global Bispecific Antibody Therapeutic Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Bispecific Antibody Therapeutic Capacity by Manufacturers
3.1.2 Global Bispecific Antibody Therapeutic Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Bispecific Antibody Therapeutic Revenue by Manufacturers (2014-2019)
3.2.2 Bispecific Antibody Therapeutic Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Bispecific Antibody Therapeutic Market Concentration Ratio (CR5 and HHI)
3.3 Bispecific Antibody Therapeutic Price by Manufacturers
3.4 Key Manufacturers Bispecific Antibody Therapeutic Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Bispecific Antibody Therapeutic Market
3.6 Key Manufacturers Bispecific Antibody Therapeutic Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Bearing An Fc Region Production and Production Value (2014-2019)
4.1.2 Lacking An Fc Region Production and Production Value (2014-2019)
4.2 Global Bispecific Antibody Therapeutic Production Market Share by Type
4.3 Global Bispecific Antibody Therapeutic Production Value Market Share by Type
4.4 Bispecific Antibody Therapeutic Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Bispecific Antibody Therapeutic Consumption by Application
6 Production by Regions
6.1 Global Bispecific Antibody Therapeutic Production (History Data) by Regions 2014-2019
6.2 Global Bispecific Antibody Therapeutic Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Bispecific Antibody Therapeutic Production Growth Rate 2014-2019
6.3.2 United States Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Bispecific Antibody Therapeutic Import & Export
6.4 Europe
6.4.1 Europe Bispecific Antibody Therapeutic Production Growth Rate 2014-2019
6.4.2 Europe Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Bispecific Antibody Therapeutic Import & Export
6.5 China
6.5.1 China Bispecific Antibody Therapeutic Production Growth Rate 2014-2019
6.5.2 China Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Bispecific Antibody Therapeutic Import & Export
6.6 Japan
6.6.1 Japan Bispecific Antibody Therapeutic Production Growth Rate 2014-2019
6.6.2 Japan Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Bispecific Antibody Therapeutic Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia
7 Bispecific Antibody Therapeutic Consumption by Regions
7.1 Global Bispecific Antibody Therapeutic Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Bispecific Antibody Therapeutic Consumption by Type
7.2.2 North America Bispecific Antibody Therapeutic Consumption by Application
7.2.3 North America Bispecific Antibody Therapeutic Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Bispecific Antibody Therapeutic Consumption by Type
7.3.2 Europe Bispecific Antibody Therapeutic Consumption by Application
7.3.3 Europe Bispecific Antibody Therapeutic Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Bispecific Antibody Therapeutic Consumption by Type
7.4.2 Asia Pacific Bispecific Antibody Therapeutic Consumption by Application
7.4.3 Asia Pacific Bispecific Antibody Therapeutic Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Bispecific Antibody Therapeutic Consumption by Type
7.5.2 Central & South America Bispecific Antibody Therapeutic Consumption by Application
7.5.3 Central & South America Bispecific Antibody Therapeutic Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Bispecific Antibody Therapeutic Consumption by Type
7.6.2 Middle East and Africa Bispecific Antibody Therapeutic Consumption by Application
7.6.3 Central & South America Bispecific Antibody Therapeutic Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 Creative-biolabs
8.1.1 Creative-biolabs Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Bispecific Antibody Therapeutic
8.1.4 Bispecific Antibody Therapeutic Product Introduction
8.1.5 Creative-biolabs Recent Development
8.2 PharmAbcine
8.2.1 PharmAbcine Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Bispecific Antibody Therapeutic
8.2.4 Bispecific Antibody Therapeutic Product Introduction
8.2.5 PharmAbcine Recent Development
8.3 Sorrento Therapeutics
8.3.1 Sorrento Therapeutics Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Bispecific Antibody Therapeutic
8.3.4 Bispecific Antibody Therapeutic Product Introduction
8.3.5 Sorrento Therapeutics Recent Development
8.4 Patheon
8.4.1 Patheon Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Bispecific Antibody Therapeutic
8.4.4 Bispecific Antibody Therapeutic Product Introduction
8.4.5 Patheon Recent Development
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Bispecific Antibody Therapeutic Capacity, Production Forecast 2019-2025
9.1.2 Global Bispecific Antibody Therapeutic Production Value Forecast 2019-2025
9.2 Bispecific Antibody Therapeutic Production and Production Value Forecast by Regions
9.2.1 Global Bispecific Antibody Therapeutic Production Value Forecast by Regions
9.2.2 Global Bispecific Antibody Therapeutic Production Forecast by Regions
9.3 Bispecific Antibody Therapeutic Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Bispecific Antibody Therapeutic Production Forecast by Type
9.4.2 Global Bispecific Antibody Therapeutic Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Bispecific Antibody Therapeutic Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Bispecific Antibody Therapeutic Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Bispecific Antibody Therapeutic Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Bispecific Antibody Therapeutic Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Bispecific Antibody Therapeutic Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Bispecific Antibody Therapeutic Sales Channels
11.2.2 Bispecific Antibody Therapeutic Distributors
11.3 Bispecific Antibody Therapeutic Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Figure Bispecific Antibody Therapeutic Product Picture
Table Bispecific Antibody Therapeutic Key Market Segments
Table Major Manufacturers Bispecific Antibody Therapeutic Covered in This Report
Table Global Bispecific Antibody Therapeutic Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Bispecific Antibody Therapeutic Sales Market Shar by Type 2014-2025
Figure Bearing An Fc Region Figures
Table Major Manufacturers of Bearing An Fc Region
Figure Lacking An Fc Region Figures
Table Major Manufacturers of Lacking An Fc Region
Table Global Bispecific Antibody Therapeutic Market Share by Application 2019-2025 (K Units)
Figure Osteology Use Case
Figure Pulmonary Use Case
Figure Respiratory Diseases Use Case
Figure Oncology Use Case
Figure Gene Therapy Use Case
Figure Bispecific Antibody Therapeutic Report Years Considered
Figure Global Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2025 (Million US$)
Figure Global Bispecific Antibody Therapeutic Production 2014-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Capacity 2014-2025 (K Units)
Table Key Manufacturers Bispecific Antibody Therapeutic Capacity (K Units)
Figure Global Bispecific Antibody Therapeutic Price 2014-2025 (USD/Unit)
Table Global Bispecific Antibody Therapeutic Market Size of Key Regions (Million USD) & (K Units)
Table Global Bispecific Antibody Therapeutic Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Bispecific Antibody Therapeutic Market Share for of Regions 2019-2025 (K Units)
Table Market Top Trends
Table Global Bispecific Antibody Therapeutic Capacity by Manufacturers (2014-2019) (K Units)
Table Global Bispecific Antibody Therapeutic Capacity Market Share by Manufacturers (2014-2019)
Table Global Bispecific Antibody Therapeutic Production by Manufacturers (2014-2019) (K Units)
Table Global Bispecific Antibody Therapeutic Production Share by Manufacturers (2014-2019)
Figure Global Bispecific Antibody Therapeutic Production Share by Manufacturers in 2018
Table Bispecific Antibody Therapeutic Revenue by Manufacturers (2014-2019) (Million USD)
Table Bispecific Antibody Therapeutic Revenue Share by Manufacturers (2014-2019)
Figure Bispecific Antibody Therapeutic Value Share by Manufacturers in 2018
Table Global Bispecific Antibody Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Bispecific Antibody Therapeutic Price by Manufacturers 2014-2019 (USD/Unit)
Table Key Manufacturers Bispecific Antibody Therapeutic Plants/Factories Distribution
Table Key Manufacturers Bispecific Antibody Therapeutic Area Served
Table Date of Key Manufacturers Enter into Bispecific Antibody Therapeutic Market
Table Key Manufacturers Bispecific Antibody Therapeutic Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Bearing An Fc Region Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Lacking An Fc Region Production and Production Value (2014-2019) (K Units) & (Million US$)
Table Global Bispecific Antibody Therapeutic Production by Type (2014-2019) (K Units)
Table Global Bispecific Antibody Therapeutic Production Share by Type (2014-2019)
Figure Global Bispecific Antibody Therapeutic Production Market Share by Type (2014-2019)
Figure Global Bispecific Antibody Therapeutic Production Market Share by Type in 2018
Table Global Bispecific Antibody Therapeutic Production Value by Type (2014-2019) (Million US$)
Table Global Bispecific Antibody Therapeutic Production Value Share by Type (2014-2019)
Figure Global Bispecific Antibody Therapeutic Production Value Market Share by Type (2014-2019)
Figure Global Bispecific Antibody Therapeutic Production Value Market Share by Type in 2018
Table Bispecific Antibody Therapeutic Ex-factory Price by Type 2014-2019 (USD/Unit)
Table Global Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Table Global Bispecific Antibody Therapeutic Consumption Share by Application (2014-2019)
Figure Global Consumption Bispecific Antibody Therapeutic Market Share by Application (2014-2019)
Table Global Bispecific Antibody Therapeutic Production by Regions 2014-2019 (K Units)
Table Global Bispecific Antibody Therapeutic Production Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Production Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Production Market Share by Regions in 2018
Table Global Bispecific Antibody Therapeutic Production Value by Regions 2014-2019 (Million USD)
Table Global Bispecific Antibody Therapeutic Production Value Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Production Value Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Production Value Market Share by Regions in 2018
Table United States Bispecific Antibody Therapeutic Production and Value 2014-2019 (K Units) & (Million USD)
Figure United States Bispecific Antibody Therapeutic Production Growth Rate 2014-2019 (K Units)
Figure United States Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019 (Million USD)
Table United States Bispecific Antibody Therapeutic Import & Export (K Units)
Table Europe Bispecific Antibody Therapeutic Production and Value 2014-2019 (K Units) & (Million USD)
Figure Europe Bispecific Antibody Therapeutic Production Growth Rate 2014-2019 (K Units)
Figure Europe Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019 (Million USD)
Table Europe Bispecific Antibody Therapeutic Import & Export (K Units)
Table China Bispecific Antibody Therapeutic Production and Value 2014-2019 (K Units) & (Million USD)
Figure China Bispecific Antibody Therapeutic Production Growth Rate 2014-2019 (K Units)
Figure China Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019 (Million USD)
Table China Bispecific Antibody Therapeutic Import & Export (K Units)
Table Japan Bispecific Antibody Therapeutic Production and Value 2014-2019 (K Units) & (Million USD)
Figure Japan Bispecific Antibody Therapeutic Production Growth Rate 2014-2019 (K Units)
Figure Japan Bispecific Antibody Therapeutic Production Value Growth Rate 2014-2019 (Million USD)
Table Japan Bispecific Antibody Therapeutic Import & Export (K Units)
Table Global Bispecific Antibody Therapeutic Consumption by Regions 2014-2019 (K Units)
Table Global Bispecific Antibody Therapeutic Consumption Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Consumption Market Share by Regions 2014-2019
Figure Global Bispecific Antibody Therapeutic Consumption Market Share by Regions in 2018
Figure North America Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table North America Bispecific Antibody Therapeutic Consumption by Type (2014-2019) (K Units)
Figure North America Bispecific Antibody Therapeutic Consumption Market Share by Type in 2018
Table North America Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Figure North America Bispecific Antibody Therapeutic Consumption Market Share by Application in 2018
Table North America Bispecific Antibody Therapeutic Consumption by Countries (2014-2019) (K Units)
Figure North America Bispecific Antibody Therapeutic Consumption Market Share by Countries in 2018
Figure United States Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Canada Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Mexico Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Europe Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table Europe Bispecific Antibody Therapeutic Consumption by Type (2014-2019) (K Units)
Figure Europe Bispecific Antibody Therapeutic Consumption Market Share by Type in 2018
Table Europe Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Figure Europe Bispecific Antibody Therapeutic Consumption Market Share by Application in 2018
Table Europe Bispecific Antibody Therapeutic Consumption by Countries (2014-2019) (K Units)
Figure Europe Bispecific Antibody Therapeutic Consumption Market Share by Countries in 2018
Figure Germany Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure France Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure UK Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Italy Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Russia Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table Asia Pacific Bispecific Antibody Therapeutic Consumption by Type (2014-2019) (K Units)
Figure Asia Pacific Bispecific Antibody Therapeutic Consumption Market Share by Type in 2018
Table Asia Pacific Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Figure Asia Pacific Bispecific Antibody Therapeutic Consumption Market Share by Application in 2018
Table Asia Pacific Bispecific Antibody Therapeutic Consumption by Regions (2014-2019) (K Units)
Table Asia Pacific Bispecific Antibody Therapeutic Consumption Market Share by Countries (2014-2019)
Figure China Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Japan Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure South Korea Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure India Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Australia Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Indonesia Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Thailand Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Malaysia Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Philippines Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Vietnam Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Central & South America Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table Central & South America Bispecific Antibody Therapeutic Consumption by Type (2014-2019) (K Units)
Figure Central & South America Bispecific Antibody Therapeutic Consumption Market Share by Type in 2018
Table Central & South America Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Figure Central & South America Bispecific Antibody Therapeutic Consumption Market Share by Application in 2018
Table Central & South America Bispecific Antibody Therapeutic Consumption by Countries (2014-2019) (K Units)
Figure Central & South America Bispecific Antibody Therapeutic Consumption Market Share by Countries
Figure Brazil Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table Middle East and Africa Bispecific Antibody Therapeutic Consumption by Type (2014-2019) (K Units)
Figure Middle East and Africa Bispecific Antibody Therapeutic Consumption Market Share by Type in 2018
Table Middle East and Africa Bispecific Antibody Therapeutic Consumption by Application (2014-2019) (K Units)
Figure Middle East and Africa Bispecific Antibody Therapeutic Consumption Market Share by Application in 2018
Figure Turkey Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure GCC Countries Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure Egypt Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Figure South Africa Bispecific Antibody Therapeutic Consumption Growth Rate (2014-2019) (K Units)
Table Creative-biolabs Company Details
Table Creative-biolabs Description and Business Overview
Table Creative-biolabs Bispecific Antibody Therapeutic Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Creative-biolabs Bispecific Antibody Therapeutic Production Growth Rate (2014-2019)
Table Creative-biolabs Bispecific Antibody Therapeutic Production Market Share in Global Market
Table Creative-biolabs Recent Development
Table PharmAbcine Company Details
Table PharmAbcine Description and Business Overview
Table PharmAbcine Bispecific Antibody Therapeutic Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table PharmAbcine Bispecific Antibody Therapeutic Production Growth Rate (2014-2019)
Table PharmAbcine Bispecific Antibody Therapeutic Production Market Share in Global Market
Table PharmAbcine Recent Development
Table Sorrento Therapeutics Company Details
Table Sorrento Therapeutics Description and Business Overview
Table Sorrento Therapeutics Bispecific Antibody Therapeutic Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sorrento Therapeutics Bispecific Antibody Therapeutic Production Growth Rate (2014-2019)
Table Sorrento Therapeutics Bispecific Antibody Therapeutic Production Market Share in Global Market
Table Sorrento Therapeutics Recent Development
Table Patheon Company Details
Table Patheon Description and Business Overview
Table Patheon Bispecific Antibody Therapeutic Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Patheon Bispecific Antibody Therapeutic Production Growth Rate (2014-2019)
Table Patheon Bispecific Antibody Therapeutic Production Market Share in Global Market
Table Patheon Recent Development
Table Global Bispecific Antibody Therapeutic Capacity, Production Forecast 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Capacity Forecast 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Forecast 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Value Forecast 2019-2025 (Million US$)
Table Global Bispecific Antibody Therapeutic Revenue Forecast 2019-2025 (Million US$)
Table Global Bispecific Antibody Therapeutic Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Bispecific Antibody Therapeutic Production Value Forecast by Regions 2019-2025 (Million US$)
Figure Global Bispecific Antibody Therapeutic Production Value Market Share Forecast by Regions 2019-2025
Table Global Bispecific Antibody Therapeutic Production Forecast by Regions 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Forecast by Regions 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Market Share Forecast by Regions 2019-2025
Table United States Bispecific Antibody Therapeutic Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure United States Bispecific Antibody Therapeutic Production Forecast 2019-2025 (K Units)
Figure United States Bispecific Antibody Therapeutic Revenue Forecast 2019-2025 (Million US$)
Table Europe Bispecific Antibody Therapeutic Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Europe Bispecific Antibody Therapeutic Production Forecast 2019-2025 (K Units)
Figure Europe Bispecific Antibody Therapeutic Revenue Forecast 2019-2025 (Million US$)
Table China Bispecific Antibody Therapeutic Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure China Bispecific Antibody Therapeutic Production Forecast 2019-2025 (K Units)
Figure China Bispecific Antibody Therapeutic Revenue Forecast 2019-2025 (Million US$)
Table Japan Bispecific Antibody Therapeutic Production and Value Forecast 2019-2025 (K Units) & (Million US$)
Figure Japan Bispecific Antibody Therapeutic Production Forecast 2019-2025 (K Units)
Figure Japan Bispecific Antibody Therapeutic Revenue Forecast 2019-2025 (Million US$)
Table Global Bispecific Antibody Therapeutic Production Forecast by Type 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Forecast by Type 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Production Market Share Forecast by Type 2019-2025
Table Global Bispecific Antibody Therapeutic Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Bispecific Antibody Therapeutic Production Value Forecast by Type 2019-2025 (Million US$)
Figure Global Bispecific Antibody Therapeutic Production Value Market Share Forecast by Type 2019-2025
Table Global Bispecific Antibody Therapeutic Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Consumption Market Share Forecast by Application 2019-2025
Table Global Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Bispecific Antibody Therapeutic Consumption Market Share Forecast by Regions 2019-2025
Table North America Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure United States Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Canada Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Mexico Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Table Europe Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure Germany Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure France Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure UK Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Italy Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Russia Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Table Asia Pacific Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure China Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Japan Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure South Korea Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure India Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Australia Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Indonesia Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Thailand Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Malaysia Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Philippines Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Vietnam Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Table Central & South America Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure Brazil Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Table Middle East and Africa Bispecific Antibody Therapeutic Consumption Forecast by Regions 2019-2025 (K Units)
Figure Turkey Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure GCC Countries Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Egypt Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure South Africa Bispecific Antibody Therapeutic Consumption Forecast 2019-2025 (K Units)
Figure Bispecific Antibody Therapeutic Value Chain
Table Bispecific Antibody Therapeutic Distributors List
Table Bispecific Antibody Therapeutic Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
寄生虫性疾患の世界市場：市場規模・現状・予測 Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.In 2018, the global Parasitic Diseases Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx%…- 世界のがん用二重特異性抗体市場：専門的調査 Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy. The global Bispecific Antibodies for Cancer market was valued at xx million US$ in…
- 次世代抗体療法の世界市場：市場規模・現状・予測 The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.Geographically, North America dominates the next-generatio…
- モノクローナル抗体カスタムサービスの世界市場：市場規模・現状・予測 Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…